Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 217

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 217
---
 trading on the NYSE of Clearwater Common Stock to be issued pursuant to the Merger 
 Agreement; and                                                                                                  |

| • |     | solely with respect of the Second Merger; the Second Merger Conditions. |

In addition, the obligation of the Buyer Parties to consummate the Transactions is subject to the satisfaction or waiver by Clearwater of each of the following additional conditions:

| • |     | the representations and warranties of Enfusion relating to certain aspects of Enfusion’s corporate existence                                                                                                                                   
 and power, corporate authorization, certain aspects of Enfusion’s capitalization, brokers’ fees and anti-takeover provisions being true and correct in all material respects on the Closing Date as if made on the Closing Date (except to the 
 extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty being true and correct in all material respects only as of such earlier date) after disregarding all   
 “materiality,” “Enfusion Material Adverse Effect” and similar qualifications;                                                                                                                                                                  |

| • |     | the representations and warranties of Enfusion relating to certain aspects of Enfusion’s capitalization                                                                                                                                                  
 being true and correct in all respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be 
 true and correct in all respects only as of such specified date), except where the failure to be so true and correct would not reasonably be expected to result in additional cost, expense or liability to Clearwater that would be more than de        
 minimis;                                                                                                                                                                                                                                                 |

| • |     | the representations and warranties of Enfusion relating to absence of changes being true and correct in all 
 respects on the Closing Date as if made on the Closing Date;                                                |

| • |     | the other representations and warranties of Enfusion being true and correct on the Closing Date as if made on the                                                                                                                                       
 Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct only as of such earlier date), except where the failure of 
 such representations and warranties to be so true and correct (disregarding all qualifications or limitations as to “materiality,” “Enfusion Material Adverse Effect” or words of similar import) would not, individually or in the                     
 aggregate, have a Enfusion Material Adverse Effect;                                                                                                                                                                                                     |

138